NLS

Carola Lemne takes over the post as CEO for Svenskt Näringsliv, the Confederation of Swedish Enterprise, after Urban Bäckström who is resigning. Lemne is assuming office in May 2014, according to a press release from Svenskt Näringsliv, where it is also stated that Lemne has had several leading positions in the global industry such as Pharmacia […]

The portfolio companies Pergamum, Inhalation Sciences Sweden (ISS) and XSpray Microparticles have been awarded research grants totaling more than EUR 1 million. Pergamum has been allocated EUR 250,000, ISS EUR 384,000 and XSpray Microparticles EUR 401,000. The grant is within the framework of the international research project FORMAMP. The goal is to develop new ways to treat […]

Bayer HealthCare announced recently that the company has received the marketing approval for Xofigo by the Norwegian Medicines Agency. Xofigo (radium Ra 223 dichloride) has been developed by Algeta. In September 2009, the two companies signed an agreement for the further development and commercialization of radium-223. Xofigo is produced in Norway at the Institute for Energy Technology (IFE) at […]

The US Food and Drug Administration, FDA, has granted orphan drug designation for the company’s liver specific contrast agent CMC-001. The Orphan Drug Designation has been granted for CMC-001 for use as a targeted contrast agent for diagnostic MRI for detection and localization of focal liver lesions in patients where gadolinium-based contrast agents are contraindicated […]

Oslo Cancer Cluster gets a new General Manager next spring.

Researchers at SciLifeLab has been granted money from Uppsala BIO-X to develop a new lab-on-a-chip diagnostic tool for early and rapid diagnosis of sepsis. The technique that the SciLifeLab researchers are working on is a lab-on-a-chip system for fast detection of bacteria in the blood. “Targeted antibiotic prescription is hampered by the lack of rapid diagnostic […]